BFM
MDT icon

Boothbay Fund Management’s Medtronic MDT Stock Holding History

Boothbay Fund Management’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-2,700
Closed -$218K – 2262
2022
Q3 		$218K Buy
+2,700
New +$243K 0.01% 1770
2022
Q2 		– Sell
-6,000
Closed -$666K – 2499
2022
Q1 		$666K Buy
+6,000
New +$634K 0.02% 1147

Other funds holding MDT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Boothbay Fund Management's MDT Position: Q2 2026 in Review

Boothbay Fund Management increased its Medtronic (MDT) stake by 152% in Q2 2026, buying an estimated $458K and bringing the position to 9,417 shares worth $737K. The position accounts for 0.01% of the portfolio, ranked #1278.

Boothbay Fund Management first reported a position in MDT in Q1 2016 and has held it in 33 quarters since. The position peaked at $17.7M in Q1 2024. 2,146 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Boothbay Fund Management held 9,417 shares of Medtronic worth $737K as of Q2 2026.
  • Boothbay Fund Management bought 5,682 Medtronic shares in Q2 2026, an estimated $458K.
  • Medtronic made up 0.01% of Boothbay Fund Management's portfolio in Q2 2026, its #1278 holding.
  • Boothbay Fund Management first reported a position in Medtronic in Q1 2016 and has held it in 33 quarters since.
  • Boothbay Fund Management's Medtronic position peaked at $17.7M in Q1 2024.
  • 2,146 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Boothbay Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.